Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels-Reference-Cited by-同舟云学术

Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels

Published:2004-05 Issue:1-2 Volume:276 Page:41-49
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Agrawal Shrutidevi,Singh Inderjit,Kaur Kanwal Jit,Bhade Shantaram R,Kaul Chaman Lal,Panchagnula Ramesh

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference34 articles.

1. Acocella, G., 1989. Human bioavailability studies. IUATLD Symposium on Quality Control of Anti-tuberculosis Drugs, Dubrovnik, 6 October 1988. Bull. Int. Union Tuberc. Lung Dis. 64, 38–40.

2. Agrawal, S., Panchagnula, R., 2004, Dissolution test as a surrogate for quality evaluation of rifampicin containing fixed dose combination formulations. (Communicated).

3. Bioequivalence of isoniazid in two drug fixed dose combination and in a single drug dosage form;Agrawal;Pharmazie,2001

4. Assessment of bioequivalence of rifampicin, isoniazid and pyrazinamide in a four drug fixed dose combination with separate formulations at the same dose levels;Agrawal;Int. J. Pharm.,2002

5. Bioequivalence assessment of rifampicin, isoniazid and pyrazinamide in a fixed dose combination of rifampicin, isoniazid, pyrazinamide and ethambutol vs. separate formulations at the same dose levels;Agrawal;Int. J. Clin. Pharmacol. Ther.,2002

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of Previous Tuberculosis Treatment History in Patients with Treatment Failure and the Impact on Acquired Drug-Resistant Tuberculosis;Antibiotics;2023-03-16

2. Development of respirable rifampicin loaded bovine serum albumin formulation for the treatment of pulmonary tuberculosis;Journal of Drug Delivery Science and Technology;2021-02

3. A Systematic Review and Meta-analysis of Isoniazid Pharmacokinetics in Healthy Volunteers and Patients with Tuberculosis;CLIN THER;2020

4. A Systematic Review and Meta-analysis of Isoniazid Pharmacokinetics in Healthy Volunteers and Patients with Tuberculosis;Clinical Therapeutics;2020-11

5. Formulation and Bioequivalence Testing of Fixed-Dose Combination Orally Disintegrating Tablets for the Treatment of Tuberculosis in the Paediatric Population;Journal of Pharmaceutical Sciences;2020-10